This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Merck & Company: Product KL-798
Frey, Sherwood C. Jr.; Bodily, Samuel E.Case DARDEN-QA-0582-EDecision AnalysisMerck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.Starting at €8.20
-
George's T-Shirts
Frey, Sherwood C. Jr.; Pfeifer, Phillip E.Case DARDEN-QA-0346-EDecision AnalysisGeorge Lasiter sells special-events T-shirts and must decide how many to order for an upcoming concert. He has high, medium, and low estimates of both concert attendance and the percentage of attendees who will want a shirt. In addition, he has assessed the relative likelihoods of each estimate. The case can be used to introduce or reinforce the fundamental issues surrounding decision making under uncertainty.Starting at €8.20
-
Merck & Company: Product KL-798 (Spanish version)
Frey, Sherwood C. Jr.; Bodily, Samuel E.Case DARDEN-QA-0910Decision AnalysisEsta es una traducción al español de la versión del 14 de junio de 2016 del caso UVA-QA-0582. Merck ha sido contactado por una pequeña empresa de investigación en biotecnología con una propuesta para que Merck compre los derechos de un nuevo medicamento que promete tratar la obesidad y reducir el colesterol. El medicamento se encuentra en la mitad de la fase I del proceso de aprobación de la FDA. Pat Harlow, el director de licencias, ha estado al...Starting at €8.20
-
Red Star Macalline: Strategic Evolution
Jie Li; Jean-Louis SchaanCase IVEY-9B17M086-EEntrepreneurship, StrategyIn 2016, the founder and chief executive officer of Red Star Macalline, China’s largest furniture shopping mall operator, was finalizing the company’s new growth plan—the “1001 Strategy.” The plan was to be implemented in two phases: first, building 1,000 brick-and-mortar shopping malls, focused on home improvement products, and then integrating the malls into a seamless ecosystem through a single overarching Internet platform. The company faced ...Starting at €8.20
-
Madison House: Riley Carter
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCase DARDEN-QA-0803-EDecision AnalysisThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, Vi...Starting at €8.20
-
PACEM: Kennedy Brooks
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCase DARDEN-QA-0802-EDecision AnalysisThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together, the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, V...Starting at €8.20
-
ArcelorMittal (B)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B10M002-EStrategyFrom the perspectives of the senior executive of Mittal and the senior executive of Arcelor, this case looks at post-merger integration. As with many mergers, the ArcelorMittal merger was touted as a merger of equals. Unlike most, it was actually managed as such and it worked. The case series looks at three critical decision points (one for each case) and challenges that the two senior executives faced from the line organization during the execut...Starting at €5.74
-
ArcelorMittal (C)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B10M003-EStrategyFrom the perspectives of the senior executive of Mittal and the senior executive of Arcelor, this case looks at post-merger integration. As with many mergers, the ArcelorMittal merger was touted as a merger of equals. Unlike most, it was actually managed as such and it worked. The case series looks at three critical decision points (one for each case) and challenges that the two senior executives faced from the line organization during the execut...Starting at €5.74
-
ArcelorMittal (A)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B10M001-EStrategyFrom the perspectives of the senior executive of Mittal and the senior executive of Arcelor, this case looks at post-merger integration. As with many mergers, the ArcelorMittal merger was touted as a merger of equals. Unlike most, it was actually managed as such and it worked. The case series looks at three critical decision points (one for each case) and challenges that the two senior executives faced from the line organization during the execut...Starting at €8.20
-
Hopax (B)
Jean-Louis Schaan; Yung-Chien LouCase IVEY-9B10M005-EEntrepreneurship, StrategyThis supplement to Hopax (A), product number 9B10M004, explains that, unlike the other players, Hopax decides to fight in court after Staples, Hopax's largest customer in the United States, decides to cancel its contract.Starting at €5.74